WASHINGTON (dpa-AFX) - S&P Global and CME Group announced the signing of a definitive agreement to sell OSTTRA, a provider of post-trade solutions for the global OTC market, to investment funds managed by KKR. The terms of the deal for OSTTRA equaled total enterprise value at $3.1 billion, which will be divided evenly between S&P Global and CME Group.
KKR is making investment in OSTTRA primarily through its North American private equity strategy. Following the close of the transaction, KKR will support OSTTRA in creating a broad-based equity ownership program to provide all of the company's nearly 1,500 employees the opportunity to participate in the benefits of ownership.
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News
